Cover Image
市場調查報告書

合成生物學:新全球市場

Synthetic Biology: Global Markets

出版商 BCC Research 商品編碼 224398
出版日期 內容資訊 英文 270 Pages
訂單完成後即時交付
價格
Back to Top
合成生物學:新全球市場 Synthetic Biology: Global Markets
出版日期: 2014年06月25日 內容資訊: 英文 270 Pages
簡介

全球的合成生物學市場在2012年為21億美元,2013年成長至27億美元。之後,預估該市場將以34.4%的CAGR擴大,在2018年成長至118億美元。

本報告調查分析合成生物學的主要製品(合成基因、合成細胞等)、實現技術(核酸定序、寡核甘酸、生物資訊學等)、整合系統、應用製品(生物燃料、特殊化學品、醫藥品等)的市場,並彙整製品種類、技術區分、終端使用者產業、區域別的市場預測、市場影響因子分析、主要企業的檔案資料等。

第1章 簡介

第2章 摘要

第3章 概要

  • 本書提及合成生物學的技術
  • 何謂合成生物學
  • 合成生物學的發展階段
  • 合成生物學市場的成長促進因子
  • 全球合成生物學相關製品市場的潛力
  • 製品及技術的生命週期的狀況
  • 合成生物學產業

第4章 合成生物學的技術

  • 簡介
  • 合成生物學的技術:概要
  • 實現技術
  • 生物學的成分與整合系統的技術
  • 應用技術
  • 途徑工程
  • 合成微生物聯合
  • R&D應用
  • 生物燃料技術

第5章 合成生物學的應用

  • 簡介
  • 實現技術的用途
  • 生物學的要素與整合系統的應用
  • 應用技術的用途

第6章 合成生物學產業

  • 價值鏈
  • 影響產業結構的因子
  • 製品、技術的生命週期
  • 基因合成產業
  • 生物燃料產業
  • 化學產業
  • 酵素產業
  • 醫藥品產業

第7章 合成生物學市場

  • 產業成長的促進因子
  • 宏觀經濟的預測前提因子
  • 合成生物學市場:終端使用者產業別
  • 合成生物學市場:製品種類別
  • 有效製品市場
  • 合成生物學市場:區域別

第8章 專利

  • 簡介
  • 合成生物學產業的專利分析
  • 主要企業的專利策略

第9章 企業檔案資料

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BIO066C

The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a compound annual growth rate (CAGR) of 34.4% over the five-year period from 2013 to 2018.

This report provides:

  • An overview of the global market for synthetic biology.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Information on the applications for synthetic biology including specialty chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms.
  • An assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
  • Comprehensive profiles of leading companies in the industry.

image1

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

BCC Research's goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a five-year period from 2013 through 2018. Our particular interest is to characterize and quantify the synthetic biology product market potential by product type and end use market segments. We also analyze the synthetic biology industry structure, competitors and intellectual property landscape. Synthetic biology markets reviewed in this report include Enabling Products, Biologic Components, Integrated Systems and Enabled Products.

Our key objective is to present a comprehensive analysis of the emerging synthetic biology industry, with an emphasis on products and technologies that are commercially important in the 2013 through 2018 time period. Market segments with rapid growth rates are highlighted, as well as those segments with large market potential. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry.

The study will be particularly useful to companies supplying synthetic genes and DNA, oligonucleotides, DNA sequencing instruments, bioinformatics, cell culture media, biofuels, specialty chemicals, pharmaceuticals, vaccines, diagnostics, agricultural seeds, pest control systems, microfluidics, and life sciences tools.

REASONS FOR DOING THE STUDY

Synthetic biology is an emerging biotechnology discipline with a wide range of applications. While there is enormous potential for future applications, synthetic biology has a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. Applications include specialty chemicals, enzymes, synthetic genes and other DNA parts as well as pharmaceuticals, diagnostics, agricultural seeds, vaccines, biofuels, and chassis microorganisms.

It is important for companies in industries impacted by synthetic biology to sort through the many potential applications; to identify near-term commercial opportunities for product development and competitive strategy. This report provides pertinent information to assist companies in prioritizing product opportunities, and establishing a solid framework for strategic planning.

Synthetic biology encompasses a range of industries including life science tools, biotechnology, pharmaceuticals, diagnostics, energy, and chemicals. Because of its wide scope, synthetic biology plays an important role in the future industrial economy.

Continuing advances in enabling technologies such as DNA synthesis and sequencing, specialty media, and bioinformatics, as well as a need for renewable feedstocks, are driving the growth of the synthetic biology market. Developments in these multidisciplinary fields promise to advance the synthetic biology industry and create unique market opportunities. This report analyzes these trends and their impact on the future markets for synthetic biology products.

Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic biology markets.

CONTRIBUTION OF THE STUDY AND FOR WHOM

We have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end-user segments of life science research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture.

We present markets by end-user segment (R&D, diagnostics and pharmaceuticals, energy, chemicals, and agriculture) and by product type (enabling products, biologic components, integrated systems, and enabled products). Key market segments are covered, including synthetic genes, agriculture, biofuels, specialty chemicals, and pharmaceuticals.

We analyze synthetic biology technologies, growth driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2013 through 2018. We project the future use of synthetic biology products in the main end-user segments and by product type.

This report will be of particular interest to companies in the industries of pharmaceuticals, chemicals, enzymes, energy, agriculture, diagnostics, bioinformatics, biotechnology, and nanobiotechnology, as well as suppliers of genomics tools, DNA synthesis and DNA sequencing products. It will also be of high interest to professionals within governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.

SCOPE AND FORMAT

The study scope includes core synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing, oligonucleotides, specialty media, bioinformatics), and enabled technologies (biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

image2

We analyze key synthetic biology technologies and products to determine present and future market status, and forecasted growth from 2013 through 2018. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market driving forces.

BCC Research examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceuticals, biofuels, and specialty chemicals. The role of key strategic alliances from 2012 through 2014 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, chassis organisms, as well as metabolically-engineered factories for producing synthetic fuels and specialty chemicals are analyzed and more than 130 companies in these fields are highlighted.

METHODOLOGY

BCC Research surveys key users and producers in each of the end-user market segments and technology fields that will be commercially important during the next five years. Discussions with industry thought leaders, as well as secondary market research was performed.

Based on our analysis, we project the future applications of synthetic biology technologies in the major end-user market segments and by technology type, and forecast sales revenues for 2013 through 2018.

INFORMATION SOURCES

BCC Research surveyed synthetic biology, biotechnology, pharmaceutical, chemical, agricultural and energy companies to obtain data for this study. Included were life science research tools, drug, biotechnology, DNA synthesis and sequencing, and microfluidics firms, as well as leading life science research institutions. We also obtained inputs from leading academic and industry thought leaders. Data from secondary sources included industry, trade, and government publications.

ANALYST'S CREDENTIALS

John Bergin is the author of previous BCC Research biotechnology reports titled Next Generation Sequencing: Emerging Clinical Applications and Global Markets; Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Applications; Biologic Imaging Reagents: Technologies and Global Markets; and Synthetic Biology: Emerging Global Markets.

Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with an emerging nanotechnology company. Mr. Bergin holds a Bachelor of Science degree in chemistry, a Master of Science degree in biotechnology, and a master's degree in business administration.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • CONTRIBUTION OF THE STUDY AND FOR WHOM
  • SCOPE AND FORMAT
  • TABLE A SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • RELATED BCC RESEARCH REPORTS
  • ANALYST'S CREDENTIALS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, 2012-2018 ($ MILLIONS)

CHAPTER 3 OVERVIEW

  • SYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT
  • TABLE 1 SCOPE OF THIS REPORT
  • FIGURE 1 SYNTHETIC BIOLOGY VALUE-ADDED CHAIN
  • WHAT IS SYNTHETIC BIOLOGY?
  • DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
  • FIGURE 2 FROM THE NATURAL TO THE ARTIFICIAL
  • TABLE 2 SYNTHETIC BIOLOGY PARADIGM
  • FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH
  • TABLE 3 SYNTHETIC BIOLOGY GROWTH: DRIVING FORCES
  • GLOBAL MARKETS FOR SYNTHETIC BIOLOGY PRODUCTS
  • TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END-USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • LIFE CYCLE STATUS OF PRODUCTS AND TECHNOLOGIES
  • TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • THE SYNTHETIC BIOLOGY INDUSTRY
  • TABLE 6 SYNTHETIC BIOLOGY COMPETITORS BY MARKET FOCUS

CHAPTER 4 SYNTHETIC BIOLOGY TECHNOLOGIES

  • INTRODUCTION
    • SYNTHETIC BIOLOGY DEFINED
    • TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
    • HISTORY OF SYNTHETIC BIOLOGY
    • TABLE 8 SYNTHETIC BIOLOGY HISTORY
    • PARADIGM SHIFT IN BIOLOGY
    • TABLE 9 PARADIGM SHIFT CAUSED BY SYNTHETIC BIOLOGY
    • SUMMARY FIGURE
    • TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
    • FIGURE 3 SCALE OF SYNTHETIC BIOLOGY
  • SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW
  • TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
  • ENABLING TECHNOLOGIES
  • TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
    • DNA SYNTHESIS AND SEQUENCING COST TRENDS
    • TABLE 13 COSTS TO SEQUENCE AND SYNTHESIZE A HUMAN GENOME, 2001-2014
    • DNA SYNTHESIS TECHNOLOGIES
    • FIGURE 4 SCHEMATIC OF GENE SYNTHESIS TECHNOLOGIES
    • TABLE 14 COMPARISONS OF GENE SYNTHESIS TECHNOLOGIES
      • PCR-based approaches
      • Solid-phase Approaches
    • MICROFLUIDIC TECHNOLOGIES
    • TABLE 15 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
      • DNA Microarrays - Oligos Synthesis
    • TABLE 16 MICROARRAY TYPES
    • TABLE 17 DNA MICROARRAY PLATFORM FEATURES
    • TABLE 18 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
    • FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
    • DNA SEQUENCING TECHNOLOGIES
    • TABLE 19 WORKFLOW COMPARISON OF SELECTED NEXT-GENERATION DNA SEQUENCING PLATFORMS
    • TABLE 20 BIOCHIP CONTENT IN NEXT-GENERATION SEQUENCING MACHINES
    • BIOINFORMATICS TECHNOLOGIES
    • TABLE 21 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
  • BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES
  • TABLE 22 NUCLEIC ACIDS, GENES, AND GENOMES
    • SYNTHETIC GENES
    • TABLE 23 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
    • TABLE 24 SYNTHETIC GENES VERSUS PCR CLONING
    • BIOBRICK PARTS
    • TABLE 25 BIOBRICK PARTS
    • FIGURE 6 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
    • MINIMAL GENOMES AND CHASSIS ORGANISMS
    • TABLE 26 ATTRIBUTES OF A MINIMAL GENOME
      • Case Study: Minimal E. coli Genome
      • Role of Directed Evolution in Designing Biologic Parts
  • ENABLED TECHNOLOGIES
  • TABLE 27 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
  • PATHWAY ENGINEERING
  • FIGURE 7 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
  • TABLE 28 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
  • SYNTHETIC MICROBIAL CONSOTRIA
  • TABLE 29 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
  • RESEARCH AND DEVELOPMENT APPLICATIONS
  • TABLE 30 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
  • BIOFUELS TECHNOLOGIES
    • OVERVIEW
    • TABLE 31 ADVANCED BIOFUELS TYPES
    • FIRST AND SECOND GENERATION BIOFUEL TECHNOLOGIES
    • TABLE 32 FIRST AND SECOND GENERATION BIOFUELS COMPARED
    • CROP FEEDSTOCKS
    • TABLE 33 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
    • CELLULOSIC FEEDSTOCKS
    • TABLE 34 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
    • TABLE 35 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
    • TABLE 36 BIOMASS ECONOMICS, 2013
    • ALGAE FEEDSTOCKS
    • TABLE 37 BIODIESEL YIELD OF SELECTED CROPS
    • CARBON DIOXIDE FEEDSTOCKS
    • BIOFUEL END PRODUCTS
    • TABLE 38 EFFICIENCY OF VARIOUS FUELS (%)
      • Cellulosic Ethanol
      • FIGURE 8 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
      • Biodiesel
      • TABLE 39 IODINE NUMBER OF VARIOUS OILS
      • Other Biofuels
      • Role of Genetic Engineering and Synthetic Biology in Biofuels
      • TABLE 40 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS

CHAPTER 5 SYNTHETIC BIOLOGY APPLICATIONS

  • INTRODUCTION
  • ENABLING TECHNOLOGIES APPLICATIONS
  • TABLE 41 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
  • BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS
  • TABLE 42 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
    • SYNTHETIC GENE APPLICATIONS
    • TABLE 43 SYNTHETIC GENES NEAR-TERM APPLICATIONS
    • BIOBRICK PARTS APPLICATIONS
    • INTEGRATED SYSTEMS APPLICATIONS
    • TABLE 44 E. COLI AS A CHASSIS ORGANISM
      • Synthetic Cells and Tissues
      • Cellular Factories
  • ENABLED PRODUCTS APPLICATIONS
  • PHARMACEUTICALS
  • TABLE 45 SYNTHETIC BIOLOGY-ENABLED DRUG CLASSES
  • TABLE 46 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
  • TABLE 47 SYNTHETIC BIOLOGY-ENABLED PHARMACEUTICAL APPLICATIONS
  • DIAGNOSTICS
  • TABLE 48 SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS APPLICATIONS
  • BIOFUELS
  • TABLE 49 SYNTHETIC BIOLOGY-ENABLED BIOFUELS APPLICATIONS
  • TABLE 50 GROWTH STATUS OF SPECIALTY VERSUS DROP-IN BIOFUELS
  • CHEMICALS
  • TABLE 51 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS
  • ENGINEERED PLANTS AND INSECTS
  • TABLE 52 SYNTHETIC BIOLOGY-ENABLED ENGINEERED PLANTS AND INSECTS APPLICATIONS
  • PRODUCTION PROCESSES
  • TABLE 53 SYNTHETIC BIOLOGY-ENABLED PRODUCTION PROCESSES APPLICATIONS

CHAPTER 6 SYNTHETIC BIOLOGY INDUSTRY

  • INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN
  • FIGURE 9 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
  • INDUSTRY STRUCTURAL FORCES
  • TABLE 54 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
  • PRODUCTS AND TECHNOLOGY LIFE CYCLE
  • TABLE 55 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • GENE SYNTHESIS INDUSTRY
    • GENE SYNTHESIS WORKFLOW
    • TABLE 56 GENE SYNTHESIS WORKFLOW
    • GENE SYNTHESIS COMPETITORS
    • TABLE 57 SYNTHETIC GENE COMPANY ESTIMATED 2013 MARKET SHARES
    • TABLE 58 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
    • GENE SYNTHESIS VALUE CHAIN
    • SYNTHETIC GENE MARKET SEGMENTS
      • Standardized Segment
      • Value Added Segment
      • TABLE 59 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
  • BIOFUEL INDUSTRY
    • COMPETITIVE DIFFERENTIATION
    • FEEDSTOCKS
    • TABLE 60 BIOFUELS: FEEDSTOCKS, PRODUCTION AND PRODUCTS
    • TABLE 61 BIOFUELS FEEDSTOCKS: RELATIVE SUPPLY VOLUME AND COSTS
    • TABLE 62 BIODIESEL YIELD OF SELECTED CROPS
    • BIOFUEL COMPETITOR STRATEGIES
    • TABLE 63 SYNTHETIC BIOLOGY BIOFUELS COMPANY STRATEGIES
    • TABLE 64 UNITED STATES SYNTHETIC BIOLOGY-ENABLED BIOFUELS CAPACITY, 2013-2018
  • CHEMICALS INDUSTRY
  • TABLE 65 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS
  • TABLE 66 VALUE-ADDED IN SELECTED END MARKETS ($/TON)
  • ENZYMES INDUSTRY
  • TABLE 67 SYNTHETIC BIOLOGY ENZYME COMPANY KEY ALLIANCES
  • PHARMACEUTICALS INDUSTRY
  • TABLE 68 PHARMACEUTICAL COMPANY SYNTHETIC BIOLOGY STRATEGIES
  • ACQUISITIONS AND STRATEGIC ALLIANCES
  • TABLE 69 SYNTHETIC BIOLOGY INDUSTRY ACQUISITIONS, 2012 THROUGH 2014
  • TABLE 70 STRATEGIC ALLIANCES, 2012-2014

CHAPTER 7 SYNTHETIC BIOLOGY MARKETS

  • INDUSTRY GROWTH DRIVING FORCES
  • TABLE 71 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
  • SYNTHETIC BIOLOGY MARKETS BY END USER INDUSTRY
  • TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • R&D MARKET
    • TABLE 73 GLOBAL VALUE OF R &D MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • DIAGNOSTICS AND PHARMACEUTICALS MARKET
    • TABLE 74 GLOBAL VALUE OF DIAGNOSTICS AND PHARMACEUTIALS MARKET BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • CHEMICALS MARKET
    • TABLE 75 GLOBAL VALUE OF CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • ENERGY MARKET
    • TABLE 76 GLOBAL VALUE OF ENERGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • AGRICULTURE MARKET
    • TABLE 77 GLOBAL VALUE OF AGRICULTURE MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPE
    • TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • ENABLING PRODUCTS MARKETS
    • TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 80 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • BIOLOGIC COMPONENTS MARKET
    • TABLE 81 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY TYPE, THROUGH 2018 ($ MILLIONS)
      • Synthetic Gene Standardized Market Segment
      • Synthetic Gene Value added Market Segment
      • TABLE 82 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • INTEGRATED SYSTEMS MARKET
    • TABLE 83 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY TYPE, THROUGH 2018 ($ MILLIONS)
      • Integrated Systems Market by Industry
      • TABLE 84 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • ENABLED PRODUCTS MARKET
    • Sources of Competitive Advantage
    • TABLE 85 BIODIESEL FUEL PERFORMANCE COMPARISON
    • TABLE 86 ARTEMISININ DRUG PRODUCTION COMPARISON
    • TABLE 87 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLED PRODUCTS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • DIAGNOSTICS AND PHARMACEUTICALS MARKET
    • TABLE 88 GLOBAL VALUE OF ENABLED DIAGNOSTIC AND PHARMACEUTICALS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
    • TABLE 89 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS MARKET, BY INDICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 90 FOOD DIAGNOSTICS INDUSTRY, 2013 ($ MILLIONS/%)
    • TABLE 91 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET, BY DRUG CLASS, THROUGH 2018 ($ MILLIONS)
    • CHEMICALS MARKET
    • TABLE 92 FACTORS FOR SYNTHETIC BIOLOGY-BASED CHEMICAL PROCESSES
    • TABLE 93 GLOBAL VALUE OF ENABLED CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
    • BIOFUELS MARKET
    • TABLE 94 ADVANCED BIOFUEL GROWTH DRIVING FACTORS
    • TABLE 95 KEY SYNTHETIC BIOLOGY-BIOFUEL ALLIANCES: 2012 THROUGH 2014
    • TABLE 96 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED BIOFUELS MARKET, BY FUEL TYPE, THROUGH 2018 ($ MILLIONS)
    • AGRICULTURE MARKET
    • TABLE 97 GLOBAL VALUE OF AGRICULTURE MARKET, BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • SYNTHETIC BIOLOGY MARKET BY REGION
    • ALL SYNTHETIC BIOLOGY PRODUCTS BY REGION
    • TABLE 98 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
    • ENABLING PRODUCTS MARKET BY GEOGRAPHY
    • TABLE 99 GLOBAL VALUE OF ENABLING PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
    • CORE PRODUCTS BY REGION
    • TABLE 100 GLOBAL VALUE OF CORE PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
    • ENABLED PRODUCTS BY REGION
    • TABLE 101 GLOBAL VALUE OF ENABLED PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)

CHAPTER 8 PATENTS

  • INTRODUCTION
  • TABLE 102 SYNTHETIC BIOLOGY PATENT SCOPE
  • FOUNDATIONAL PATENTS
  • TABLE 103 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
  • SYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSIS
  • TABLE 104 SYNTHETIC BIOLOGY PATENT LANDSCAPE, BY COMPANY
  • TABLE 105 PATENT DESCRIPTION BY COMPANY
  • PATENT STRATEGY OF SELECTED COMPANIES
    • METABOLIX
    • DUPONT
    • GENEART (LIFE TECHNOLOGIES)

CHAPTER 9 COMPANY PROFILES

  • ACTIVE MOTIF
  • AGILIS BIOTHERAPEUTICS LLC
  • AGRIVIDA
  • TABLE 106 AGRIVIDA TECHNICAL APPROACH
  • ALGENICS
  • ALGENOL BIOFUELS
  • ALGENUITY
  • ALLYLIX
  • AMBRX INC.
  • AMYRIS INC.
  • TABLE 107 AMYRIS BIODIESEL ADVANTAGES
  • ARZEDA CORP.
  • ATG BIOSYNTHETICS GMBH
  • AUTODESK INC.
  • AVIDBIOTICS CORP.
  • BACTERIAL ROBOTICS LLC
  • BASF AG
  • BAYER AG
  • BETA RENEWABLES
  • BIOAMBER INC.
  • BIO BASIC CANADA INC.
  • BIOMAX INFORMATICS AG
  • BIONEER CORP.
  • BIONEXUS INC.
  • BIOSEARCH TECHNOLOGIES INC.
  • BIO S&T INC.
  • BLUE MARBLE BIOMATERIALS
  • BRITISH PETROLEUM
  • CALYSTA ENERGY INC.
  • CAMBRIAN GENOMICS INC.
  • CARIBOU BIOSCIENCES INC.
  • CELLECTIS SA
  • CHEVRON CORP.
  • COBALT TECHNOLOGIES
  • CODEXIS INC.
  • DEMURIS LTD.
  • DESKTOP GENETICS LTD.
  • DNA2.0
  • DOW CHEMICAL COMPANY
  • E.I DU PONT DE NEMOURS AND COMPANY
  • DYADIC INTERNATIONAL INC.
  • ENBIOTIX INC.
  • ENEVOLV INC.
  • EPOCH LIFE SCIENCE INC.
  • EUROFINS MWG OPERON
  • EVOLUTIONARY SOLUTIONS INC.
  • EVOLVA SA
  • TABLE 108 EVOLVA'S GENETIC CHEMISTRY PLATFORM
  • TABLE 109 EVOLVA PRODUCT STATUS
  • EVOZYM BIOLOGICS INC.
  • EXXONMOBILE CORP.
  • GEN9 INC.
  • TABLE 110 LINEAR GENE SYNTHESIS PRODUCTS
  • GENABLER LTD.
  • GENEMED SYNTHESIS INC.
  • GENEWORKS PTY. LTD.
  • GENEORACLE INC.
  • GENOMATICA
  • GENOME COMPILER CORP.
  • GENSCRIPT USA INC.
  • GEVO INC.
  • GINKGO BIOWORKS
  • GLOBAL BIOENERGIES
  • GLOWING PLANT
  • GLYCOS BIOTECHNOLOGIES INC.
  • GOODYEAR TIRE & RUBBER CO.
  • GREEN BIOLOGICS LTD.
  • HELIX NANOTECHNOLOGIES INC.
  • ILLUMINA INC.
  • INGENZA LTD.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • INTERNATIONAL BUSINESS MACHINES
  • INTREXON CORP.
  • TABLE 111 INTREXON ULTRAVECTOR PARTS INVENTORY EXAMPLES
  • TABLE 112 INTREXON CHANNEL PARTNER STATUS
  • IOGEN CORP.
  • JOULE UNLIMITED
  • LABGENIUS LTD.
  • LANZATECH
  • LATTICE AUTOMATION
  • LC SCIENCES
  • LS9 INC.
  • LYGOS INC.
  • MASCOMA CORP.
  • MERCK & CO.
  • METABOLIX INC.
  • TABLE 113 MIREL COMPETITORS IN BIOPLASTICS
  • MICHELIN SA
  • MICROSOFT CORP.
  • MODULAR GENETICS
  • MORPH BIOINFORMATICS
  • MORPHOSYS AG
  • MYRIANT CORP.
  • NEW ENGLAND BIOLABS
  • NOVACTA BIOSYSTEMS LTD.
  • NOVARTIS AG
  • TABLE 114 STEPS TO PRODUCE SYNTHETIC BIOLOGICALLY-DERIVED FLU SEED
  • NOVOZYMES A/S
  • OMEGA BIO-TEK INC.
  • OPX BIOTECHNOLOGIES INC.
  • ORAGENICS
  • ORIGENE TECHNOLOGIES INC.
  • OXITEC LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC.
  • PARETO BIOTECHNOLOGIES INC.
  • PEACCEL INC.
  • PFIZER
  • PHYLOGIA LIMITED
  • PHYTOWELT GREEN TECHNOLOGIES GMBH
  • PROKARIUM LTD.
  • PROTERRO INC.
  • QTEROS INC.
  • RADIANT GENOMICS INC.
  • REFACTORED MATERIALS
  • RENNOVIA INC.
  • ROOSTERBIO INC.
  • ROYAL DSM N.V.
  • SAMPLE6
  • SANGAMO BIOSCIENCES INC.
  • TABLE 115 SANGAMO KEY STRATEGIC ALLIANCES
  • SANOFI AVENTIS
  • SAPPHIRE ENERGY
  • SCARAB GENOMICS LLC.
  • SEA6 ENERGY LTD.
  • SGI-DNA INC.
  • SHANGHAI GENERAY BIOTECH CO. LTD.
  • SHANGHAI SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SILICOLIFE LDA.
  • SOLAZYME INC.
  • TABLE 116 FACTORS AFFECTING BIOFUELS ADOPTION
  • SOLIGENIX INC.
  • SUTRO BIOPHARMA INC.
  • SYNPROMICS LTD.
  • SYNTHACE LTD.
  • SYNTHETIC BIOLOGICS INC.
  • SYNTHETIC GENOMICS INC.
  • SYNTHORX INC.
  • TAURIGA SCIENCES INC.
  • TESELAGEN BIOTECHNOLOGY INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TRITON ALGAE INNOVATIONS LTD.
  • UNIVERSAL BIOMINING
  • VERDEZYNE INC.
  • VG LIFE SCIENCES INC.
  • ZIOPHARM ONCOLOGY INC.

LIST OF TABLES

  • TABLE A SCOPE OF REPORT
  • SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 1 SCOPE OF THIS REPORT
  • TABLE 2 SYNTHETIC BIOLOGY PARADIGM
  • TABLE 3 SYNTHETIC BIOLOGY GROWTH: DRIVING FORCES
  • TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END-USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • TABLE 6 SYNTHETIC BIOLOGY COMPETITORS BY MARKET FOCUS
  • TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
  • TABLE 8 SYNTHETIC BIOLOGY HISTORY
  • TABLE 9 PARADIGM SHIFT CAUSED BY SYNTHETIC BIOLOGY
  • TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
  • TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
  • TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
  • TABLE 13 COSTS TO SEQUENCE AND SYNTHESIZE A HUMAN GENOME, 2001-2014
  • TABLE 14 COMPARISONS OF GENE SYNTHESIS TECHNOLOGIES
  • TABLE 15 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
  • TABLE 16 MICROARRAY TYPES
  • TABLE 17 DNA MICROARRAY PLATFORM FEATURES
  • TABLE 18 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
  • TABLE 19 WORKFLOW COMPARISON OF SELECTED NEXT-GENERATION DNA SEQUENCING PLATFORMS
  • TABLE 20 BIOCHIP CONTENT IN NEXT-GENERATION SEQUENCING MACHINES
  • TABLE 21 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
  • TABLE 22 NUCLEIC ACIDS, GENES, AND GENOMES
  • TABLE 23 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
  • TABLE 24 SYNTHETIC GENES VERSUS PCR CLONING
  • TABLE 25 BIOBRICK PARTS
  • TABLE 26 ATTRIBUTES OF A MINIMAL GENOME
  • TABLE 27 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
  • TABLE 28 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
  • TABLE 29 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
  • TABLE 30 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
  • TABLE 31 ADVANCED BIOFUELS TYPES
  • TABLE 32 FIRST AND SECOND GENERATION BIOFUELS COMPARED
  • TABLE 33 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
  • TABLE 34 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
  • TABLE 35 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
  • TABLE 36 BIOMASS ECONOMICS, 2013
  • TABLE 37 BIODIESEL YIELD OF SELECTED CROPS
  • TABLE 38 EFFICIENCY OF VARIOUS FUELS (%)
  • TABLE 39 IODINE NUMBER OF VARIOUS OILS
  • TABLE 40 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
  • TABLE 41 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
  • TABLE 42 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
  • TABLE 43 SYNTHETIC GENES NEAR-TERM APPLICATIONS
  • TABLE 44 E. COLI AS A CHASSIS ORGANISM
  • TABLE 45 SYNTHETIC BIOLOGY-ENABLED DRUG CLASSES
  • TABLE 46 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
  • TABLE 47 SYNTHETIC BIOLOGY-ENABLED PHARMACEUTICAL APPLICATIONS
  • TABLE 48 SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS APPLICATIONS
  • TABLE 49 SYNTHETIC BIOLOGY-ENABLED BIOFUELS APPLICATIONS
  • TABLE 50 GROWTH STATUS OF SPECIALTY VERSUS DROP-IN BIOFUELS
  • TABLE 51 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS
  • TABLE 52 SYNTHETIC BIOLOGY-ENABLED ENGINEERED PLANTS AND INSECTS APPLICATIONS
  • TABLE 53 SYNTHETIC BIOLOGY-ENABLED PRODUCTION PROCESSES APPLICATIONS
  • TABLE 54 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
  • TABLE 55 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • TABLE 56 GENE SYNTHESIS WORKFLOW
  • TABLE 57 SYNTHETIC GENE COMPANY ESTIMATED 2013 MARKET SHARES
  • TABLE 58 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
  • TABLE 59 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
  • TABLE 60 BIOFUELS: FEEDSTOCKS, PRODUCTION AND PRODUCTS
  • TABLE 61 BIOFUELS FEEDSTOCKS: RELATIVE SUPPLY VOLUME AND COSTS
  • TABLE 62 BIODIESEL YIELD OF SELECTED CROPS
  • TABLE 63 SYNTHETIC BIOLOGY BIOFUELS COMPANY STRATEGIES
  • TABLE 64 UNITED STATES SYNTHETIC BIOLOGY-ENABLED BIOFUELS CAPACITY, 2013-2018
  • TABLE 65 SYNTHETIC BIOLOGY-ENABLED CHEMICALS APPLICATIONS
  • TABLE 66 VALUE-ADDED IN SELECTED END MARKETS ($/TON)
  • TABLE 67 SYNTHETIC BIOLOGY ENZYME COMPANY KEY ALLIANCES
  • TABLE 68 PHARMACEUTICAL COMPANY SYNTHETIC BIOLOGY STRATEGIES
  • TABLE 69 SYNTHETIC BIOLOGY INDUSTRY ACQUISITIONS, 2012 THROUGH 2014
  • TABLE 70 STRATEGIC ALLIANCES, 2012-2014
  • TABLE 71 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
  • TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY END USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 73 GLOBAL VALUE OF R &D MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 74 GLOBAL VALUE OF DIAGNOSTICS AND PHARMACEUTIALS MARKET BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 75 GLOBAL VALUE OF CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 76 GLOBAL VALUE OF ENERGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 77 GLOBAL VALUE OF AGRICULTURE MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 80 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLING PRODUCTS, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 81 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 82 GLOBAL VALUE OF BIOLOGIC COMPONENTS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 83 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 84 GLOBAL VALUE OF INTEGRATED SYSTEMS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 85 BIODIESEL FUEL PERFORMANCE COMPARISON
  • TABLE 86 ARTEMISININ DRUG PRODUCTION COMPARISON
  • TABLE 87 GLOBAL VALUE OF SYNTHETIC BIOLOGY ENABLED PRODUCTS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 88 GLOBAL VALUE OF ENABLED DIAGNOSTIC AND PHARMACEUTICALS MARKET, BY INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 89 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED DIAGNOSTICS MARKET, BY INDICATION, THROUGH 2018 ($ MILLIONS)
  • TABLE 90 FOOD DIAGNOSTICS INDUSTRY, 2013 ($ MILLIONS/%)
  • TABLE 91 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET, BY DRUG CLASS, THROUGH 2018 ($ MILLIONS)
  • TABLE 92 FACTORS FOR SYNTHETIC BIOLOGY-BASED CHEMICAL PROCESSES
  • TABLE 93 GLOBAL VALUE OF ENABLED CHEMICALS MARKET, BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 94 ADVANCED BIOFUEL GROWTH DRIVING FACTORS
  • TABLE 95 KEY SYNTHETIC BIOLOGY-BIOFUEL ALLIANCES: 2012 THROUGH 2014
  • TABLE 96 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED BIOFUELS MARKET, BY FUEL TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 97 GLOBAL VALUE OF AGRICULTURE MARKET, BY APPLICATION, THROUGH 2018 ($ MILLIONS)
  • TABLE 98 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
  • TABLE 99 GLOBAL VALUE OF ENABLING PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
  • TABLE 100 GLOBAL VALUE OF CORE PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
  • TABLE 101 GLOBAL VALUE OF ENABLED PRODUCTS MARKET, BY REGION, THROUGH 2018 ($ MILLIONS)
  • TABLE 102 SYNTHETIC BIOLOGY PATENT SCOPE
  • TABLE 103 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
  • TABLE 104 SYNTHETIC BIOLOGY PATENT LANDSCAPE, BY COMPANY
  • TABLE 105 PATENT DESCRIPTION BY COMPANY
  • TABLE 106 AGRIVIDA TECHNICAL APPROACH
  • TABLE 107 AMYRIS BIODIESEL ADVANTAGES
  • TABLE 108 EVOLVA'S GENETIC CHEMISTRY PLATFORM
  • TABLE 109 EVOLVA PRODUCT STATUS
  • TABLE 110 LINEAR GENE SYNTHESIS PRODUCTS
  • TABLE 111 INTREXON ULTRAVECTOR PARTS INVENTORY EXAMPLES
  • TABLE 112 INTREXON CHANNEL PARTNER STATUS
  • TABLE 113 MIREL COMPETITORS IN BIOPLASTICS
  • TABLE 114 STEPS TO PRODUCE SYNTHETIC BIOLOGICALLY-DERIVED FLU SEED
  • TABLE 115 SANGAMO KEY STRATEGIC ALLIANCES
  • TABLE 116 FACTORS AFFECTING BIOFUELS ADOPTION

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET, BY PRODUCT TYPE, 2012-2018 ($ MILLIONS)
  • FIGURE 1 SYNTHETIC BIOLOGY VALUE-ADDED CHAIN
  • FIGURE 2 FROM THE NATURAL TO THE ARTIFICIAL
  • SUMMARY FIGURE
  • FIGURE 3 SCALE OF SYNTHETIC BIOLOGY
  • FIGURE 4 SCHEMATIC OF GENE SYNTHESIS TECHNOLOGIES
  • FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
  • FIGURE 6 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
  • FIGURE 7 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
  • FIGURE 8 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
  • FIGURE 9 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
Back to Top